Navigation Links
Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy
Date:8/14/2014

technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Forward Looking Statements

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and statements regarding the company's clinical development of KB001-A, KB004 and KB003. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the potential timing and outcomes of clinical studies of KB001-A and KB004 undertaken now or in the future; the potential, if any, for future development of KB003; the company's limited cash reserves and its ability to obtain additional capital on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that the company has initiated or plans to initiate; the company's dependence on Sanofi Pasteur for the manufacture, development and commercialization of KB001-A; the company's ability to successfully progress or complete further development of its programs; the uncertainties inherent in clinical testing; the timing, cost and uncertainty of obtaining regulatory approvals
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
2. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
3. Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
4. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
5. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
6. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
7. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
8. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
9. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
10. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
11. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Oct. 29, 2014  BioMed Realty Trust, Inc. (NYSE: ... company focusing on life sciences, today announced financial ... 2014. Third Quarter 2014 Highlights Financial ... leasing transactions during the quarter representing approximately 657,700 ... for the third quarter of approximately 219,700 square ...
(Date:10/27/2014)... Oct. 27, 2014  RenovoRx, a leading developer of ... delivery of fluids to selected sites in the vascular ... has appointed Shaun Bagai as Chief Executive ... Board of Directors. Bagai brings more than 15 years ... Bagai joined RenovoRx in June 2014 and in his ...
(Date:10/27/2014)... , Oct. 27, 2014 Research and ... H1N1 Vaccines Market 2014-2018" report to their offering. ... humans caused by a variant of the swine H1N1 virus, ... virus which infects nose, throat, and lungs. H1N1 virus is ... viruses infect different animal species such as humans, swine, birds, ...
Breaking Medicine Technology:BioMed Realty Trust Reports Third Quarter 2014 Financial Results 2BioMed Realty Trust Reports Third Quarter 2014 Financial Results 3BioMed Realty Trust Reports Third Quarter 2014 Financial Results 4BioMed Realty Trust Reports Third Quarter 2014 Financial Results 5BioMed Realty Trust Reports Third Quarter 2014 Financial Results 6BioMed Realty Trust Reports Third Quarter 2014 Financial Results 7BioMed Realty Trust Reports Third Quarter 2014 Financial Results 8BioMed Realty Trust Reports Third Quarter 2014 Financial Results 9BioMed Realty Trust Reports Third Quarter 2014 Financial Results 10BioMed Realty Trust Reports Third Quarter 2014 Financial Results 11BioMed Realty Trust Reports Third Quarter 2014 Financial Results 12BioMed Realty Trust Reports Third Quarter 2014 Financial Results 13BioMed Realty Trust Reports Third Quarter 2014 Financial Results 14BioMed Realty Trust Reports Third Quarter 2014 Financial Results 15BioMed Realty Trust Reports Third Quarter 2014 Financial Results 16BioMed Realty Trust Reports Third Quarter 2014 Financial Results 17BioMed Realty Trust Reports Third Quarter 2014 Financial Results 18BioMed Realty Trust Reports Third Quarter 2014 Financial Results 19BioMed Realty Trust Reports Third Quarter 2014 Financial Results 20BioMed Realty Trust Reports Third Quarter 2014 Financial Results 21RenovoRx Board Names Shaun R. Bagai as CEO 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3
... , FRANKLIN, Mass., Sept. 14 PLC ... cardiac and vascular medical device-based technologies, today announced that a paper ... in conjunction with autologous stem cells was presented at ESC Congress ... Barcelona, Spain. , , This study ...
... ORLANDO, Florida, September 14 ... Clinical Surveillance System Will Help Novant,Hospitals Ensure Patient Safety ... MEDai, Inc., an Elsevier company and leading provider ... today that Novant Health, a not-for-profit integrated group of,hospitals ...
Cached Medicine Technology:Study on PLC Systems' TMR Therapy With Stem Cells Presented at ESC 2009 2Study on PLC Systems' TMR Therapy With Stem Cells Presented at ESC 2009 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 2Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 3Novant Health Rolls Out MEDai's Predictive Modeling Solution to Nine Hospitals in Three States 4
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... been identified that appear linked to autism spectrum disorders, ... are on their way to discovering up to 1,000 ... Autism spectrum disorders include a range of developmental disabilities ... An estimated one in 68 U.S. children has an ...
(Date:10/30/2014)... 30, 2014 Horse Sense & ... riding to special needs individuals in the Jacksonville area, ... November 15 from 10-2:00 p.m. at Bailey's Farm (2202 ... to the public and is designed to raise awareness ... to the HSS Round-Up is free. Ticket purchases will ...
(Date:10/30/2014)... 30, 2014 The human brain is ... vigorously exercised to help maintain better mental health, according ... ‘Dementia Express: Lose Your Memory in 100 Ways’ for ... and sometimes conflicting attitudes to help keep the reader ... a reader must decipher the hidden logic within. , ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... Many U.S. colleges have indoor tanning salons on ... risk for skin cancer, researchers report. Tanning ... so colleges should adopt tanning-free policies, to help ... health efforts are needed to raise university administration ... indoor tanning poses to young adults in order ...
Breaking Medicine News(10 mins):Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... Alcohol Support Team Board of Directors and Commits all ... Corporate Charity Work to Benefit FASTeam, ... a year, more than Spina Bifida, Down Syndrome and Muscular,Dystrophy ... an,increase in efforts to promote prevention of prenatal alcohol exposure ...
... LAKE FOREST, Ill., July 7 Hospira, Inc.,(NYSE: ... today announced that it will host a conference call ... 2008, at 8 a.m. Central,time., The company will ... stock market open and the conference call., A ...
... 100%, ARLINGTON HEIGHTS, Ill., July 7 ... are satisfied with,their decision, have low complication rates ... study in July,s Plastic and Reconstructive Surgery(R), the,official ... Surgeons,(ASPS). In addition, breast reconstruction after preventive mastectomy ...
... 2 should be tested for high cholesterol, group says , , ... to the impact of the childhood obesity epidemic in the ... kids as young as 8 years old be given cholesterol-lowering ... , The American Academy of Pediatrics also recommends that children ...
... AIDS Fundraising Event Goes GREEN with Online ... Communications, Recycling and Awareness, SAN FRANCISCO, July ... Francisco announced today key initiatives to ,Green, the,HIV fundraising event ... introduction of Green Walkers, composting, and,enhanced recycling., "With the ...
... MEETING, Pa., July 7 /Xinhua-PRNewswire/ -- BMP ... ,Company,) today,announced that it received the New ... enterprise with foreign investment in the People,s,Republic ... Industry and,Commerce (SHAIC). With receipt of this ...
Cached Medicine News:Health News:K Squared Sponsors F.A.S.T. Ride 150-mile Motorcycle Tour August 17 2Health News:98% of Elective Mastectomy Patients Would Have Reconstruction Again, Says ASPS Study 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 3Health News:AIDS Walk San Francisco Takes Big Green Step Forward 2Health News:AIDS Walk San Francisco Takes Big Green Step Forward 3Health News:BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd 2
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
... The Kawesch-Lancaster Lasik speculum ... one curved to provide clearance ... solid blades retract the lids ... path for the microkeratome. The ...
Medicine Products: